Dr Nicola S Meagher
Dr Nicola S Meagher
Verified email at
Cited by
Cited by
Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients
R Na, AE Grulich, NS Meagher, GW McCaughan, AM Keogh, CM Vajdic
American Journal of Transplantation 13 (1), 174-183, 2013
Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006
MT van Leeuwen, JJ Turner, DJ Joske, MO Falster, P Srasuebkul, ...
International journal of cancer 135 (9), 2146-2156, 2014
De novo Cancer‐Related Death in Australian Liver and Cardiothoracic Transplant Recipients
R Na, AE Grulich, NS Meagher, GW McCaughan, AM Keogh, CM Vajdic
American Journal of Transplantation 13 (5), 1296-1304, 2013
Role of radiotherapy in early glottic carcinoma
RI Smee, NS Meagher, JR Williams, K Broadley, GP Bridger
Head & neck 32 (7), 850-859, 2010
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and …
NS Meagher, L Wang, PF Rambau, MP Intermaggio, DG Huntsman, ...
Modern Pathology 32 (12), 1834-1846, 2019
Survival after cutaneous melanoma in kidney transplant recipients: a population‐based matched cohort study
CM Vajdic, AH Chong, PJ Kelly, NS Meagher, MT Van Leeuwen, ...
American Journal of Transplantation 14 (6), 1368-1375, 2014
Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure
MT van Leeuwen, JJ Turner, MO Falster, NS Meagher, DJ Joske, ...
International journal of cancer 133 (4), 944-951, 2013
Recurrent nasopharyngeal carcinoma: current management approaches
RI Smee, NS Meagher, K Broadley, T Ho, JR Williams, GP Bridger
American journal of clinical oncology 33 (5), 469-473, 2010
The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study
A Swart, L Burns, L Mao, AE Grulich, J Amin, DL O'Connell, NS Meagher, ...
BMJ open 2 (5), 2012
High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: a population-based cohort study
R Na, MA Laaksonen, AE Grulich, NS Meagher, GW McCaughan, ...
Journal of the American Academy of Dermatology 74 (6), 1144-1152. e6, 2016
Iatrogenic immunosuppression and risk of non‐Hodgkin lymphoma in solid organ transplantation: A population‐based cohort study in Australia
R Na, MA Laaksonen, AE Grulich, NS Meagher, GW McCaughan, ...
British journal of haematology 174 (4), 550-562, 2016
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
EY Kang, D Cheasley, C LePage, MJ Wakefield, M da Cunha Torres, ...
Modern Pathology 34 (1), 194-206, 2021
The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: an Australian population-based cohort study
CM Vajdic, SM Pour, J Olivier, A Swart, DL O’Connell, MO Falster, ...
Drug and alcohol dependence 152, 264-271, 2015
Retained role of surgery for olfactory neuroblastoma
RI Smee, K Broadley, JR Williams, NS Meagher, GP Bridger
Head & neck 33 (10), 1486-1492, 2011
Medulloblastoma: progress over time
RI Smee, JR Williams, KJ De‐loyde, NS Meagher, R Cohn
Journal of medical imaging and radiation oncology 56 (2), 227-234, 2012
Integration and analysis of heterogeneous colorectal cancer data for translational research
J Jonnagaddala, JL Croucher, TR Jue, NS Meagher, L Caruso, R Ward, ...
Nursing Informatics 2016, 387-391, 2016
An audit of cancer of unknown primary notifications: a cautionary tale for population health research using cancer registry data
CM Vajdic, CC Er, A Schaffer, T Dobbins, L Wyld, NS Meagher, J Barrett, ...
Cancer epidemiology 38 (4), 460-464, 2014
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in …
K Heinze, TM Nazeran, S Lee, P Krämer, ES Cairns, DS Chiu, SCY Leung, ...
The Journal of pathology 256 (4), 388-401, 2022
Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials
NS Meagher, K Schuster, A Voss, T Budden, CNI Pang, A deFazio, ...
Gynecologic oncology 150 (3), 527-533, 2018
Examining the quality of name code record linkage: what is the impact on death and cancer risk estimates? A validation study
A Swart, NS Meagher, MT van Leeuwen, K Zhao, A Grulich, L Mao, ...
Australian and New Zealand journal of public health 39 (2), 141-147, 2015
The system can't perform the operation now. Try again later.
Articles 1–20